Cell Free RNA Testing Market to Surpass USD 4.9 Billion by 2032, Growing at 10.6% CAGR
The global Cell Free Rna Testing Market is witnessing significant expansion due to the rapid adoption of liquid biopsy technologies and precision medicine. The market was valued at approximately USD 1.9 billion in 2023 and is projected to reach USD 4.9 billion by 2032, registering a compound annual growth rate (CAGR) of 10.6% between 2024 and 2032. Growing prevalence of cancer and...
0 Kommentare 0 Geteilt 24 Ansichten 0 Bewertungen